These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 5482199)

  • 1. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 3. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience of the People's Republic of Bulgaria in controlling diphtheria, tetanus and whooping cough].
    Polikar ACh; Solomonova KM; Mikhaĭlova VP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):92-6. PubMed ID: 3874506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diphtheria and tetanus toxoids].
    Smith JW
    Bol Oficina Sanit Panam; 1973 Feb; 74(2):152-65. PubMed ID: 4265717
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory testing of combined diphtheria-tetanus-pertussis-typhoid vaccines.
    Csizér Z; Joó I; Réthy L; Juhász VP
    Prog Immunobiol Stand; 1971; 5():394-8. PubMed ID: 4660543
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
    Durbacă S; Andronescu C; Diaconescu A
    Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 17. A collaborative investigation of a potency assay for adsorbed tetanus vaccines based on the protection of mice from tetanic paralysis.
    Mussett MV; Sheffield F
    J Biol Stand; 1976 Apr; 4(2):141-8. PubMed ID: 932045
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphtheria and tetanus toxoids.
    Smith JW
    Br Med Bull; 1969 May; 25(2):177-82. PubMed ID: 4918532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic testing of associated whooping cough-diphtheria-tetanus vaccine with smaller doses of individual components].
    Polikar A; Solomonova K; Mikhailova V; Atanasova P; Khadzhikoleva Kh
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Aug; 50(8):88-92. PubMed ID: 4784594
    [No Abstract]   [Full Text] [Related]  

  • 20. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.